Expert discusses how, despite its importance, albuminuria screening remains underutilized, and improving adherence to dual ...

Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

Elevidys now carries a black box warning for acute liver injury and failure, limiting its use to ambulatory patients aged four and older. The FDA's actions follow fatal liver failure reports in ...

The results speak plainly. Spain spends 9.2 percent of GDP on health care; we spend 17.2 percent. Spaniards live to an ...

Here’s what you missed this week on Managed Healthcare Executive. Each Sunday we feature a highlight reel of various articles posted on our website that week. We’ll be back on Monday morning with more ...

Newly analyzed data from Japan adds to the evidence that COVID-19 may increase the risk of shingles.

Veterans who enter the healthcare workforce have a 29% higher chance at promotion and have a 14% higher retention rate than ...

Menopause care is not one-size-fits-all, especially for gender nonconforming individuals, including transgender, nonbinary ...

The findings showed that disease progression not only worsens patient outcomes but also significantly increases overall healthcare costs. Late-stage disease and post-recurrence cystectomy were ...

The BEACON study used de-identified data from the Tempus Database, assessing IB6 expression via immunohistochemistry.

More than half of melanoma patients whose cancer initially responds to immunotherapy will eventually see their disease return ...

Expert discusses how the prevalence of chronic kidney disease (CKD), as reflected by decreased estimated glomerular ...